Growth Metrics

Core Laboratories (CLB) Accounts Payables (2022 - 2026)

Core Laboratories filings provide 5 years of Accounts Payables readings, the most recent being $40.0 million for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 3.86% to $40.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $40.0 million, a 3.86% increase, with the full-year FY2025 number at $37.3 million, up 7.89% from a year prior.
  • Accounts Payables hit $40.0 million in Q1 2026 for Core Laboratories, up from $37.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $45.8 million in Q4 2022 to a low of $32.5 million in Q1 2024.
  • Median Accounts Payables over the past 5 years was $36.9 million (2025), compared with a mean of $37.3 million.
  • Biggest five-year swings in Accounts Payables: fell 26.92% in 2023 and later rose 18.5% in 2025.
  • Core Laboratories' Accounts Payables stood at $45.8 million in 2022, then fell by 26.92% to $33.5 million in 2023, then rose by 3.11% to $34.5 million in 2024, then increased by 7.89% to $37.3 million in 2025, then increased by 7.26% to $40.0 million in 2026.
  • The last three reported values for Accounts Payables were $40.0 million (Q1 2026), $37.3 million (Q4 2025), and $36.9 million (Q3 2025) per Business Quant data.